Effects of DL-endopeptidase Producing Probiotics on Human Intestinal NOD2 Ligands and Related Functions

Effects of DL-endopeptidase Produced by Probiotics on Human Intestinal NOD2 Ligands and Related Functions

We have discovered a type of probiotic that can target activating intestinal NOD2, which is related to a series of human health issues.

This trial requires the subjects to take probiotics for a certain period of time, and we will collect blood, stool and questionnaires for subsequent testing, efficacy evaluation and safety evaluation.

Inclusion Criteria:

• Tend to participate the trial
• Willing to provide written informed consent

Exclusion Criteria:

• Recent use of probiotics, antibiotics, laxatives, or gastrointestinal ulcer medications within the past month.
• Gastrointestinal symptoms (e.g., constipation, abdominal pain, diarrhea, melena, hematochezia) in the past month.
• Other conditions considered by researchers for exclusion